THRD Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 154268 min ago

@ $9.00

Išleistas: 13 vas. 2024 @ 19:30

Grąža: 51.67%

Ankstesnis signalas: vas. 6 - 20:49

Ankstesnis signalas: Pardavimas

Grąža: -2.39 %

Live Chart Being Loaded With Signals

Commentary (30 geg. 2024 @ 23:00):

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases...

Stats
Šios dienos apimtis	36 685.00
Vidutinė apimtis	151 632
Rinkos kapitalizacija	558.96M
EPS	$0.195 ( 2024-05-16 )
Kita pelno data	( $-0.340 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-18.20
ATR14	$0.0420 (0.31%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-20	Dittman Jennifer	Sell	1 042	Employee Stock Option (right to buy)
2024-05-20	Dittman Jennifer	Sell	1 042	Common Stock
2024-05-20	Dittman Jennifer	Sell	1 042	Common Stock
2024-05-16	Dinsmore Christopher	Buy	210 000	Employee Stock Option (right to buy)
2024-05-16	Dinsmore Christopher	Buy	0

INSIDER POWER
46.58
Last 96 transactions
Buy: 6 105 206 \| Sell: 2 714 663

Tūris Koreliacija

Ilgas: -0.09 (neutral)

Trumpas: 0.10 (neutral)

Signal:(47.554) Neutral

Third Harmonic Bio, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Third Harmonic Bio, Inc. Koreliacija - Valiuta/Žaliavos

0.06
( neutral )

0.11
( neutral )

0.00
( neutral )

0.29
( neutral )

-0.17
( neutral )

0.48
( neutral )

Third Harmonic Bio, Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-35 000.00 (0.00 %)
EPS:	$-0.780

FY	2023
Pajamos:	$0
Bruto pelnas:	$-35 000.00 (0.00 %)
EPS:	$-0.780

FY	2022
Pajamos:	$0
Bruto pelnas:	$-38 000.00 (0.00 %)
EPS:	$-0.960

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-1.730

Financial Reports:

No articles found.

Third Harmonic Bio, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.